In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  7-hydroxystaurosporine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000256600, PMH-PHL-006, NCI-5538, 5538, NCT00045513

2.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCSF-NCI-5522, NCI-5522, NCT00030888, 5522

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-02049, NCI-5509, 5509, NCT00045747

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000339563, PMH-PHL-019, NCI-6402, 6402, NCT00072267

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 7 and over
Sponsor: NCI
Protocol IDs: 040173, 04-C-0173, NCI-04-C-0173, NCI-6070, 6070, NCT00085319, NCT00082017

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03092, 6992, PHL032, N01CM62203, PMH-PHL-032, NCI-6992, NCT00098956

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02829, PHII-33, 5536, N01CM17101, CCC-PHII-33, UCD-200311478-01, CHNMC-PHII-33, NCI-5536, NCT00072189

8.

Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-95-C-0171N, NCI-T95-0052N, T95-0052

9.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J9814, CDR0000066221, U01CA070095, P30CA006973, JHOC-98012305, NCI-T97-0083, NCT00003289

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000067252, NCI-99-C-0127, NCI-T99-0022, T99-0022, NCT00019838

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-9924, NCI-T99-0037, NCT00004059, T99-0037

12.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: DM99-165, U01CA062461, P30CA016672, MDA-DM-99165, NCI-T99-0100, CDR0000067522, T99-0100, NCT00004263

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068274, U01CA062505, P30CA033572, CHNMC-PHI-28, NCI-T99-0065, T99-0065, NCT00006464

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00019, NCI-5582, WUSM-SCC-0102, CDR0000069215, UVACC-SCC-0102, SCC 01-02, 5582, P30CA044579, NCT00031681

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00042, UMGCC 0143, MSGCC-0143, NCI-5533, CDR0000069321, U01CA069854, 5533, NCT00036777

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02468, DM01-553, U01CA062461, CDR0000069380, MDA-DM-01553, NCI-5510, 5510, NCT00039403

17.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000256599, NCI-02-C-0241, NCI-5694, 5694, NCT00045500

18.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000256917, PMH-PHL-005, NCI-5518, 5518, NCT00045175

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0173, CDR0000257566, U01CA070095, P30CA006973, JHOC-J0173, NCI-5528, 5528, NCT00047242

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00149, MSGCC-0507, NCI-7311, MSGCC-H-27229-0507, CDR0000465368, GCC 0507, 7311, NCT00301938

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000069478, NCI-NAVY-01-04, NCI-5535, NCI-02-C-0222, NCT00042861
New Search